Join us & The Carroll Center for the Blind this #WorldSightDay for the “Journey Through Vision Loss” event. Hear from @fightblindness.bsky.social, mental health experts & advocates, plus updates on our #RNAExonEditing candidate ACDN-01 & the #STELLAR trial in #StargardtDisease. 🧷 bit.ly/42bSmsd

What’s top of mind for biotech CFOs in 2025 and beyond? Our Chief Financial & Business Officer Daniel Rosan joins Informa’s ‘CFO Corner’ to talk biotech trends, deals, and what’s next for leadership in 2025 and beyond. Don’t miss it: bit.ly/4lN8p6K 📍 Sept 17 | 9:45 AM 📌 Sheraton Boston

Excited to share that Ascidian is a 2025 Prix Galien USA nominee for Best Start-Up. Thank you to The Galien Foundation for the recognition, and to our #TeamAscidian colleagues for turning bold ideas into breakthroughs. Congrats to this year’s nominees! #PrixGallienUSA #RNAExonEditing #BioSky

We’re thrilled to welcome Dr. Murray A. Abramson as Chief Development Officer & announce our new Ophthalmology Clinical Advisory Board guiding ACDN-01 for #StargardtDisease. Big things ahead! 🔗 ascidian-tx.com/press-releas... #RNAExonEditing #TeamAscidian #Biosky

Smart alliances. Strategic alignment. Real talk. Ascidian’s Dan Rosan joins industry leaders for a candid panel at the Goodwin + PJT Partners session on M&A & partnering in today’s market. Don’t miss it. 🔗https://bit.ly/43AT6Z5 📍 June 18 | 12–2:30 PM 📌 Goodwin’s Boston office #BIO2025 #Biosky

At #CGTP2025 tomorrow, Ascidian’s John Kerwin joins other biotech leaders and gene-editing expert Dr. Kiran Musunuru to discuss the latest advancements in gene editing technologies and their transformative potential for patients. Don’t miss it. #RNAExonEditing #GeneTherapy

🎸 Silvi Rouskin brings rock-star creativity to RNA science—with Harvard rigor to match. A one-of-a-kind mind pushing RNA structural research forward with cutting edge techniques ⬇️ #TeamAscidian #RNAExonEditing #Biosky

🧬 A pioneer in RNA biology, Roy Parker has spent his career unraveling how life works — one molecule at a time. He’s shaped our understanding of how RNA is regulated, degraded, and stored — and why it matters. ⬇️ #RNAExonEditing #TeamAscidian #Biosky

🎓 From journalism major to expert in alternative splicing and RNA-binding proteins: a registration mix-up sparked Brenton Graveley’s path to becoming a leader in RNA biology. ⬇️ #RNAExonEditing #TeamAscidian #Biosky

We’re kicking off our SAB spotlight series with RNA- pioneer Mariano A. Garcia-Blanco. A trans-splicing trailblazer whose love for science runs generations deep ⬇️ #RNAExonEditing #TeamAscidian #Biosky

Introducing Ascidian’s Scientific Advisory Board – trailblazers in #RNA biology and gene expression who’ve made groundbreaking contributions in the field of RNA splicing and to research, mentoring and education. Join us in welcoming them 👏 #Biosky ascidian-tx.com/wp-content/u...

Our Bluesky debut! 🚀 This weekend, we joined leading retinal disease research experts at the RD Fund Investing in Cures Summit, where our CSO Robert Bell shared insights on #RNAExonEditing & #StargardtDisease. Grateful for @fightblindness.bsky.social’s leadership in this space! #biosky